Urinary Tract Infections and Surgical Site Infections due to Carbapenem-Resistant Enterobacteriaceae in Renal Transplant

Transplantation Proceedings

Volumn 48, Issue 6, 2016, Pages 2050-2055

  Rodrigues dos Santos, B G ^a,b,c   Amaral, E S ^d   Fernandes, P F C B C ^b,d   Oliveira, C M C ^b   Rodrigues, J L N ^a,b   Perdigao Neto L V ^e   Girao E S ^b,c  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b Walter Cantídio Univ Hosp   (Brazil)

^c Hospital São José de Doenças Infecciosas Fortaleza   (Brazil)

^d STATE UNIVERSITY OF CEARÁ   (Brazil)

^e UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE; POLYMYXIN;

ADULT; ADVERSE EFFECTS; ANTIBIOTIC RESISTANCE; DRUG EFFECTS; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; GRAFT RECIPIENT; HUMAN; ISOLATION AND PURIFICATION; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDY; RISK FACTOR; SURGICAL WOUND INFECTION; URINARY TRACT INFECTIONS;

ADULT; AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; CARBAPENEMS; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POLYMYXINS; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS; SURGICAL WOUND INFECTION; TRANSPLANT RECIPIENTS; URINARY TRACT INFECTIONS;

EID: 84995912080     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2016.05.005     Document Type: Article

References (33)

1. [1] Satlin, M.J., Jenkins, S.G., Walsh, T.J., The global challenge of carbapenem-resistant Enterobacteriaceae in transplant recipients and patients with hematologic malignancies. Clinical Infect Dis 58 (2014), 1274–1283.
2. [2] Nordmann, P., Cuzon, G., Naas, T., The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 9 (2009), 228–236.
3. [3] Sievert, D.M., Ricks, P., Edwards, J.R., Schneider, A., Patel, J., Srinivasan, A., et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010. Infect Control Hosp Epidemiol 34 (2013), 1–14.
4. [4] Hidron, A.I., Edwards, J.R., Patel, J., Horan, T.C., Sievert, D.M., Pollock, D.A., et al. NHSN annual update: antimicrobial- resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 29 (2008), 996–1011.
5. [5] National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 32 (2004), 470–485.
6. [6] Gales, A.C., Castanheira, M., Jones, R.N., Sader, H.S., Antimicrobial resistance among gram-negative bacilli isolated from Latin America: results from SENTRY Antimicrobial Surveillance Program (Latin America, 2008-2010). Diagn Microbiol Infect Dis 73 (2012), 354–360.
7. [7] Zarkotou, O., Pournaras, S., Tselioti, P., Dragoumanos, V., Pitiriga, V., Ranellou, K., et al. Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment. Clin Microbiol Infect 17 (2011), 1798–1803.
8. [8] Patel, G., Huprikar, S., Factor, S.H., Jenkins, S.G., Calfee, D.P., Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 29 (2008), 1099–1106.
9. [9] Schwaber, M.J., Klarfeld-Lidji, S., Navon-Venezia, S., Schwartz, D., Leavitt, A., Carmeli, Y., Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother 52 (2008), 1028–1033.
10. [10] Mouloudi, E., Protonotariou, E., Zagorianou, A., Iosifidis, E., Karapanagiotou, A., Giasnetsova, T., et al. Bloodstream infections caused by metallo-β-lactamase/Klebsiella pneumoniae carbapenemase–producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes. Infect Control Hosp Epidemiol 31 (2010), 1250–1256.
11. [11] Tumbarello, M., Trecarichi, E.M., De Rosa, F.G., Giannella, M., Giacobbe, D.R., Bassetti, M., et al. Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study. J Antimicrob Chemother 70 (2015), 2133–2143.
12. [12] Kwon, J.A., Lee, J.E., Huh, W., Peck, K.R., Kim, Y.G., Kim, D.J., et al. Predictors of acute kidney injury associated with intravenous colistin treatment. Int J Antimicrob Agents 35 (2010), 473–477.
13. [13] Taber, S.S., Pasko, D.A., The epidemiology of drug-induced disorders: the kidney. Expert Opin Drug Saf 7 (2008), 679–690.
14. [14] Transplant Observatory. http://www.transplant-observatory.org/Pages/Data-Reports.aspx/; [accessed February 24, 2016].
15. [15] Associação Brasileira de Transplantes de Órgãos (ABTO). http://www.abto.org.br/abtov03_ingles/Upload/file/BrazilianTransplantationRegistry/rbt-ing-parc.pdf/; [accessed February 28, 2016].
16. [16] Registro Brasileiro de Transplantes, Associação Brasileira de Transplantes de Órgãos (ABTO). Ano XXI N4 Pg 9.
17. [17] Eleman, A., Rahimian, J., Doymaz, M., In vitro evaluation of antibiotic synergy for polymyxin b-resistant carbapenemase producing Klebsiella pneumoniae. J Clin Microbiol 48 (2010), 3558–3562.
18. [18] Pouch, S.M., Kubin, C.J., Satlin, M.J., Tsapepas, D.S., Lee, J.R., Dube, G., et al. Epidemiology and outcomes of carbapenem-resistant Klebsiella pneumoniae bacteriuria in kidney transplant recipients. Transplant Infect Dis 17 (2015), 800–809.
19. [19] Centers for Disease Control and Prevention. http://www.cdc.gov/nhsn/PDFs/pscManual/7pscCAUTIcurrent.pdf/; [accessed March 21, 2016].
20. [20] Centers for Disease Control and Prevention. http://www.cdc.gov/nhsn/PDFs/pscManual/9pscSSIcurrent.pdf/; [accessed March 21, 2016].
21. [21] Rennie, R.P., Jones, R.N., Effects of breakpoint changes on carbapenem susceptibility rates of Enterobacteriaceae: results from the SENTRY Antimicrobial Surveillance Program, United States, 2008 to 2012. Can J Infect Dis Med Microbiol 25 (2014), 285–287.
22. [22] Centers for Disease Control and Prevention. http://www.cdc.gov/hai/organisms/cre/definition.html/; [accessed February 23, 2016].
23. [23] Bellomo, R., Ronco, C., Kellum, J.A., Mehta, R.L., Palevsky, P., Acute Dialysis Quality Initiative Work Group. Acute renal failure—definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 8 (2004), R204–R212.
24. [24] Bergamasco, M.D., Barroso Barbosa, M., de Oliveira Garcia, D., Cipullo, R., Moreira, J.C., Baia, C., et al. Infection with Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in solid organ transplantation. Transplant Infect Dis 14 (2012), 198–205.
25. [25] Freire, M.P., Abdala, E., Moura, M.L., et al. Risk factors and outcome of infections with Klebsiella pneumoniae carbapenemase-producing K. pneumoniae in kidney transplant recipients. Infection 43 (2015), 315–323.
26. [26] Simkins, J., Muggia, V., Cohen, H.W., et al. Carbapenem-resistant Klebsiella pneumoniae infections in kidney transplant recipients: a case-control study. Transplant Infect Dis 16 (2014), 775–782.
27. [27] Sqalli, T.H., Laboudi, A., Arrayhani, M., et al. Urinary tract infections in renal allograft recipients from living related donors. Saudi J Kidney Dis Transplant, 19, 2008, 551.
28. [28] Lee, G.C., Burgess, D.S., Treatment of Klebsiella pneumoniae carbapenemase (KPC) infections: a review of published case series and case reports. Ann Clin Microbiol Antimicrob, 11, 2012, 32.
29. [29] Freire, M.P., Antonopoulos, I.M., Piovesan, A.C., et al. Amikacin prophylaxis and risk factors for surgical site infection after kidney transplantation. Transplantation 99 (2015), 521–527.
30. [30] Clancy, C.J., Chen, L., Shields, R.K., Zhao, Y., Cheng, S., Chavda, K.D., et al. Epidemiology and molecular characterization of bacteremia due to carbapenem-resistant Klebsiella pneumoniae in transplant recipients. Am J Transplant 13 (2013), 2619–2633.
31. [31] Taglietti, F., Di Bella, S., Galati, V., Topino, S., Iappelli, M., Petrosillo, N., Carbapenemase-producing Klebsiella pneumoniae-related mortality among solid organ-transplanted patients: do we know enough?. Transpl Infect Dis 15 (2013), E164–E165.
32. [32] Lübbert, C., Becker-Rux, D., Rodloff, A.C., et al. Colonization of liver transplant recipients with KPC-producing Klebsiella pneumoniae is associated with high infection rates and excess mortality: a case-control analysis. Infection 42 (2014), 309–316.
33. [33] Morrill, H.J., Pogue, J.M., Kaye, K.S., et al. Treatment options for carbapenem-resistant Enterobacteriaceae infections. Open forum infectious diseases. 2015, Oxford University Press.